LINEAGE CELL THERAPEUTICS INC's ticker is LCTX and the CUSIP is 53566P109. A total of 104 filers reported holding LINEAGE CELL THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,798,230 | +76387.9% | 1,536,946 | -26.1% | 2.10% | -16.0% |
| Q3 2022 | $2,351 | -22.9% | 2,080,536 | +7.8% | 2.51% | -24.5% |
| Q2 2022 | $3,050 | +51.7% | 1,930,536 | +47.8% | 3.32% | +60.7% |
| Q1 2022 | $2,011 | +51.0% | 1,306,095 | +140.3% | 2.07% | +61.9% |
| Q4 2021 | $1,332 | +464.4% | 543,590 | +480.8% | 1.28% | +482.6% |
| Q3 2021 | $236 | +90.3% | 93,590 | +114.7% | 0.22% | +108.6% |
| Q2 2021 | $124 | +21.6% | 43,590 | 0.0% | 0.10% | +1.0% |
| Q1 2021 | $102 | – | 43,590 | – | 0.10% | – |
Download | ||||||